The GLP-1 Warning That Started a Debate
What GDF-15 May Be Telling Us About GLP-1 Risks. Forty patients, twenty using retatrutide, the others using semaglutide and tirzepatide, and a challenge from a cardiothoracic surgeon. What metformin, mitochondrial…



